Domestic pharmaceutical companies are experiencing mixed results regarding their CMO businesses for COVID-19 vaccines.

Samsung Biologics and SK Bioscience are already in the process of manufacturing COVID-19 vaccines. On the other hand, GC Pharma and Huons Global gave up their COVID-19 vaccine CMO business. In addition, uncertainties continue in Hanmi Pharmaceutical and Hankook Korus Pharm’s COVID-19 CMO businesses.

◆Korea-US CMO likely to dismantle due to discontinuation of Genexine’s COVID-19 vaccine development

According to industry sources on the 12th, Genexine applied to discontinue its ongoing Phase II/III trial for its COVID-19 vaccine, GX-19N, on the 11th.